Jinlong Wang

699 total citations
12 papers, 543 citations indexed

About

Jinlong Wang is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Jinlong Wang has authored 12 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cancer Research and 2 papers in Genetics. Recurrent topics in Jinlong Wang's work include Cancer-related molecular mechanisms research (7 papers), Circular RNAs in diseases (4 papers) and RNA Research and Splicing (4 papers). Jinlong Wang is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Circular RNAs in diseases (4 papers) and RNA Research and Splicing (4 papers). Jinlong Wang collaborates with scholars based in China and United States. Jinlong Wang's co-authors include Wenkang Luan, Yun Xia, Xuefeng Bu, Xin Ni, Feng Lu, Yan Shi, Shengnan Ruan, Kehao Le, Ting Hu and Yulan Yan and has published in prestigious journals such as Journal of Cellular Physiology, Medicine and Cell Death and Disease.

In The Last Decade

Jinlong Wang

12 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinlong Wang China 10 446 417 52 47 44 12 543
Ji Chen China 10 312 0.7× 208 0.5× 70 1.3× 80 1.7× 14 0.3× 19 439
Debina Sarkar New Zealand 6 286 0.6× 186 0.4× 49 0.9× 120 2.6× 13 0.3× 10 384
Xizi Jiang China 12 180 0.4× 85 0.2× 37 0.7× 59 1.3× 31 0.7× 26 305
Elena Grossi Italy 11 552 1.2× 403 1.0× 28 0.5× 24 0.5× 32 0.7× 19 655
R Jiang China 6 334 0.7× 236 0.6× 151 2.9× 84 1.8× 52 1.2× 9 542

Countries citing papers authored by Jinlong Wang

Since Specialization
Citations

This map shows the geographic impact of Jinlong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinlong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinlong Wang more than expected).

Fields of papers citing papers by Jinlong Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinlong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinlong Wang. The network helps show where Jinlong Wang may publish in the future.

Co-authorship network of co-authors of Jinlong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jinlong Wang. A scholar is included among the top collaborators of Jinlong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinlong Wang. Jinlong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Wang, Yuhui, et al.. (2022). Fatal community-acquired bloodstream infection caused by Klebsiella variicola : A case report. World Journal of Clinical Cases. 10(8). 2474–2483. 4 indexed citations
2.
Wang, Jinlong, et al.. (2021). Efficacy and safety of Shenling Atractylodes Powder in the treatment of ulcerative colitis. Medicine. 100(14). e25355–e25355. 1 indexed citations
3.
Dong, Fang, Shengnan Ruan, Jinlong Wang, et al.. (2020). M2 macrophage-induced lncRNA PCAT6 facilitates tumorigenesis and angiogenesis of triple-negative breast cancer through modulation of VEGFR2. Cell Death and Disease. 11(9). 728–728. 102 indexed citations
4.
Luan, Wenkang, Yuting Ding, Haitao Yuan, et al.. (2020). Long non-coding RNA LINC00520 promotes the proliferation and metastasis of malignant melanoma by inducing the miR-125b-5p/EIF5A2 axis. Journal of Experimental & Clinical Cancer Research. 39(1). 96–96. 36 indexed citations
5.
Luan, Wenkang, et al.. (2019). Long noncoding RNA LINC00518 acts as a competing endogenous RNA to promote the metastasis of malignant melanoma via miR-204-5p/AP1S2 axis. Cell Death and Disease. 10(11). 855–855. 47 indexed citations
6.
Luan, Wenkang, et al.. (2019). Long noncoding RNA OIP5‐AS1 acts as a competing endogenous RNA to promote glutamine catabolism and malignant melanoma growth by sponging miR‐217. Journal of Cellular Physiology. 234(9). 16609–16618. 31 indexed citations
7.
Wang, Jinlong, Xiuyuan Zhang, Yun Wang, et al.. (2018). KRAB-containing zinc finger protein ZNF496 inhibits breast cancer cell proliferation by selectively repressing ERα activity. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1861(9). 841–853. 10 indexed citations
8.
Luan, Wenkang, Zhou Zhou, Xin Ni, et al.. (2018). Long non-coding RNA H19 promotes glucose metabolism and cell growth in malignant melanoma via miR-106a-5p/E2F3 axis. Journal of Cancer Research and Clinical Oncology. 144(3). 531–542. 89 indexed citations
9.
Luan, Wenkang, Qian Yao, Xin Ni, et al.. (2017). miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma. OncoTargets and Therapy. Volume 10. 1237–1246. 36 indexed citations
10.
Luan, Wenkang, Liang Liu, Xin Ni, et al.. (2017). Long non-coding RNA HOTAIR acts as a competing endogenous RNA to promote malignant melanoma progression by sponging miR-152-3p. Oncotarget. 8(49). 85401–85414. 55 indexed citations
11.
Luan, Wenkang, Yan Shi, Xuefeng Bu, et al.. (2016). Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22. Oncotarget. 7(39). 63901–63912. 106 indexed citations
12.
Chong, Ling-Wa, et al.. (2015). Asiatic acid inhibits left ventricular remodeling and improves cardiac function in a rat model of myocardial infarction. Experimental and Therapeutic Medicine. 11(1). 57–64. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026